Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Can-Fite Biopharma Has Encouraging News but Will It Enthuse Investors?

September 2, 2021 0

Can-Fite Biopharma Good News We learned, from Petach Tikva, Israel, that Can-Fite Biopharma (CANF) – a biotechnology company advancing its pipeline of small molecule drugs that address inflammatory, cancer and liver diseases, announced its completion of enrollment of all patients (>400) planned for its Phase 3 Comfort™ study with the firm’s product Piclidenoson in patients with moderate to severe plaque …

Cassava Statement Regarding Plasma p-tau Analysis from a Previously Disclosed...

Agenus Good News: Balstilimab Monotherapy Data Published in Gynecologic Oncology

The US FDA Granted Fast Track Designation for Sutro Biopharma...

BeiGene Ltd and EUSA Pharma Product QARZIBA® Approval from China...

Cassava Sciences Inc: Today’s Press Releases

Cassava Sciences Announces Positive Data with SavaDx from a Randomized...

Immunome Inc Stock Rallied After Announcing it Neutralized the SARS-CoV-2...

Why Celldex Therapeutics Stock is Soaring

TRxADE HEALTH Subsidiary, Bonum Health, Signed a Telemedicine Service Distribution...

Prilenia Therapeutics’ Pridopidine Product for Huntington’s and Lou Gehrig’s Diseases...

Reata Pharmaceuticals: Good News from the FDA Regarding Omaveloxolone for...

ADC Therapeutics: Moving from a Development-Stage Firm to a Revenue-Generating...

Amylyx Pharmaceuticals: Continuing to Offer Promising Results in Treating ALS

Gilead Sciences: Another Accelerated Cancer Approval from the FDA

Exelixis Latest News. See Also: TransMedics Group May Improve on...

Intellia Therapeutics’ Important Current Presentations

Novartis Announced Positive Results of Phase 3 Study Using 177Lu-PSMA-617...

Immutep Ltd: Evaluating the Safety and Efficacy of Eftilagimod Alpha...

Aveo Oncology: The FDA Approved FOTIVDA for Adults with Relapsed...

Impacting News

BioMarin Pharmaceutical Inc Product VOXZOGO® is the First to Prevent Dwarfism in Europe

August 31, 2021 0

The most important news in biological sciences is the high degree of success the biological revolution …

Cara Therapeutics and Vifor Pharma Announced the U.S. FDA Approval of KORSUVA™

August 24, 2021 0

Cara Therapeutics and Vifor Pharma Granted US FDA Approval of KORSUVA™ Indeed, the U.S. Food and …

Travere Therapeutics: Positive Trial Results of its Product Sparsentan in Treating IgA Nephropathy

August 16, 2021 0

Travere Therapeutics Sparsentan for IgAN Positive Results Phase 3 PROTECT Study of Travere Therapeutics (TVTX) product sparsentan …

Akero Therapeutics Inc Q2 Business Updates and Financial Results

August 13, 2021 0

Akero Therapeutics Inc Akero Therapeutics Inc (AKRO) is a clinical-stage cardio-metabolic company developing transformational treatments for …

A Biotechnology Company to Remember and Appreciate

August 12, 2021 0

Vir Biotechnology: What We've Learned from Dr. George Scangos George Scangos, PhD. is the chief executive …

Reata Pharmaceuticals Two Stories: Updated News of its Clinical Programs and Finances

August 11, 2021 0

Reata Pharmaceuticals Two Stories Omaveloxolone in Patients with Friedreich’s Ataxia Several communications between Reata Pharmaceuticals (RETA) …

Trick or Trade

Why Jounce Therapeutics Stock is Outperforming Today

September 14, 2021 0

Jounce Therapeutics Jounce Therapeutics (JNCE) is a clinical-stage immunotherapy company developing therapies enabling the immune system …

Gain Therapeutics: A Biotech with Promising Treatments for Neurodegenerative Diseases and a Note from Prohost Biotech

September 8, 2021 0

Gain Therapeutics Inc in the News Gain Therapeutics, Inc. (GANX) announced today topline data from its …

The U.S. FDA Accepts Exelixis sNDA of CABOMETYX® for Priority Review

August 6, 2021 0

Exelixis sNDA Accepted by the US FDA for CABOMETYX® The U.S. Food and Drug Administration (FDA) …

Encouraging News from Hoth Therapeutics and Kintor Pharmaceutical Ltd About Treating Acne and Alopecia

July 14, 2021 0

Hoth Therapeutics Hoth Therapeutics (HOTH) announced that its product, HT-003, has yielded positive results in an …

The FDA Approval of Biogen’s Alzheimer’s Disease Drug and How Cassava Sciences Alzheimer’s Disease Drug Differs

June 12, 2021 0

Biogen Product Adulelm Approved for Alzheimer’s Disease The latest news regarding Alzheimer’s disease is that of …

It’s All About Common Sense: Intellia Therapeutics

March 9, 2021 0

The Nonsensical Downgrading of Development-Stage Firms Like Intellia Therapeutics It makes no sense to downgrade a …

Today’s Highlights

The U.S. FDA Accepted Intellia Therapeutics IND Application of NTLA-5001 for Acute Myeloid Leukemia

September 16, 2021 0

Intellia Therapeutics IND Application of NTLA-5001 for AML is Accepted by the US FDA NTLA-5001 is …

Regenxbio and AbbVie: A Good Reason for RGNX to Soar Today

September 13, 2021 0

Regenxbio and AbbVie in the NEWS Regenxbio (RGNX) stock soared today. The Company, along with AbbVie …

Why IVERIC bio Stock Rallied Today

September 10, 2021 0

IVERIC bio Stock Rally IVERIC bio (ISEE) stock rallied in early, premarket trading today as Stifel …

Interesting, Good News for Impel NeuroPharma and Migraine Sufferers

September 3, 2021 0

Impel NeuroPharma FDA Approval for TRUDHESA The U.S. Food and Drug Administration (FDA) approved Impel NeuroPharma …

Positive News for TCR2 Therapeutics – The U.S. FDA Granted Orphan Drug Designation to Gavo-Cel for Cholangiocarcinoma

September 2, 2021 0

TCR2 Therapeutics TCR2 Therapeutics (TCRR) is a clinical-stage cell therapy company developing a pipeline of novel T …

Cassava Sciences Issued a Response to Claims Posted After Market Yesterday. See Also: Cassava Sciences Good News

August 25, 2021 0

Cassava Sciences Responds to Misleading Posts Cassava Sciences (SAVA) today issued a response to claims that …

Prohost Portfolio PLUS

Companies Behind the Biotechnology Revolution

July 12, 2021 0

Prohost Portfolio PLUS #7 Companies Behind The Biotechnology Revolution Without these firms, basic science discoveries in …

Intellia Therapeutics and Regeneron Pharmaceuticals: Yes, it is a Miracle!

June 29, 2021 0

Prohost Portfolio PLUS #6 Yes, it is a Miracle! Intellia Therapeutics and Regeneron Pharmaceuticals This miracle …

Vir Biotechnology

May 4, 2021 0

Prohost Portfolio PLUS #5 Vir Biotechnology Vir Biotechnology (VIR) combines cutting-edge technologies with immunologic insights to …

Celldex Therapeutics See Also: More of Your Questions Answered

April 26, 2021 0

Prohost Portfolio PLUS #4 Celldex Therapeutics Celldex Therapeutics (CLDX) stock is gaining momentum. On April 12, …

CureVac N.V.

April 18, 2021 0

Prohost Portfolio PLUS #3 CureVac N.V. We were looking forward to learning more important details about …

Re-Working Some Evaluated Biotechnology Firms

April 11, 2021 0

Prohost Portfolio PLUS #2 Re-Working Some Evaluated Biotechnology Firms Exelixis: 2020 and 2021 Wondering why Exelixis’ …

Prohost Letters

A Reevaluation of Prohost Biotech’s Picked Firms

August 9, 2021 0

Prohost Letter #446 A Reevaluation of Prohost Biotech’s Picked Firms We have already pinpointed some of …

A Flashback and Future Projections

March 24, 2021 0

Prohost Letter #445 A Flashback and Future Projections 1. A Follow-Up on Recently Posted News from …

Prohost Letter #444

March 8, 2021 0

Prohost Letter #444 The End of the Year Issue was delayed because our 2020 Prohost Portfolio …

The Biotechnology Industry

December 8, 2020 2

Prohost Letter #443 The Biotechnology Industry The Biotechnology Industry revolutionized the arts of life sciences with …

The Whole World Against the Blind SARS-CoV-2 Virus

September 28, 2020 3

Prohost Letter 442 The Whole World Against the Blind SARS-CoV-2 Virus Investors have no doubt profited …

Are We Saying Goodbye to Common Sense?

July 3, 2020 2

Prohost Letter #441 Biotechnology Companies’ Evaluations Are We Saying Goodbye to Common Sense? The SARS-CoV-2 Vaccines …